| Trial ID: | L5072 |
| Source ID: | NCT00243984
|
| Associated Drug: |
Topiramate
|
| Title: |
Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
|
| Acronym: |
|
| Status: |
SUSPENDED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Metabolic Syndrome X|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: topiramate
|
| Outcome Measures: |
Primary: Change in weight on days 28, 56, 84, 112, 140, 168, and 175.|Waist circumference on days 1, 84 and 168.|BMI on days 1, 84, 168, and 175. | Secondary: Blood pressure on days 1, 28, 56, 84, 112, 140, 168, and 175.|Complete metabolic profile on days 84 and 168.|HbA1C on days 1, 84, and 168.|Lipid profile on days 84 and 168.|C reactive protein on days 1, 84, and 168.
|
| Sponsor/Collaborators: |
Sponsor: Northeastern Ohio Universities College of Medicine | Collaborators: Cleveland Clinic Akron General|Forum Health|Aultman Health Foundation|St. Elizabeth Health Center|Mercy Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-03
|
| Completion Date: |
2007-11
|
| Results First Posted: |
|
| Last Update Posted: |
2007-12-10
|
| Locations: |
Akron General Medical Center, Akron, Ohio, 44307, United States|Mercy Medical Center, Canton, Ohio, 44708, United States|Aultman Hospital, Canton, Ohio, 44710, United States|Forum Health/Northside Medical Center, Youngstown, Ohio, 44501, United States|St. Elizabeth Health Center, Youngstown, Ohio, 44501, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00243984
|
